A human intermediate conductance calcium-activated potassium channel

Area of Science:

• Molecular Biology
• Ion Channel Physiology
• Human Genetics

Background:

• Calcium-activated potassium channels play crucial roles in cellular excitability.
• The intermediate conductance subfamily (IK) was less characterized compared to small (SK) and large (BK) conductance channels.
• Understanding novel channel subtypes is vital for cellular function and disease research.

Purpose of the Study:

• To clone and characterize a novel human intermediate conductance calcium-activated potassium channel, designated hIK1.
• To determine the biophysical and pharmacological properties of the cloned hIK1 channel.
• To compare hIK1 with known calcium-activated potassium channels.

Main Methods:

• Cloning of hIK1 from human pancreatic cDNA.
• Expression of hIK1 in Xenopus oocytes for electrophysiological studies.
• Patch-clamp recordings to analyze ion currents, activation kinetics, and pharmacology.
• Sequence analysis to determine homology with other potassium channel subfamilies.

Main Results:

• hIK1 mRNA was detected in human peripheral tissues but not in the brain.
• Expressed hIK1 channels exhibited inwardly rectifying potassium currents activated by submicromolar intracellular calcium.
• The channel displayed a conductance of 39 pS (inward) and was sensitive to charybdotoxin and clotrimazole, but not apamin or iberiotoxin.
• Hill equation analysis revealed a reduced slope factor compared to SK channels, indicating distinct calcium sensitivity.

Conclusions:

• The cloned hIK1 represents a distinct human intermediate conductance calcium-activated potassium channel.
• Its biophysical and pharmacological profile aligns with native IK channels, such as the Gardos channel.
• hIK1's tissue distribution suggests specific roles in peripheral tissues rather than the central nervous system.